Herpes zoster and postherpetic neuralgia

Essentials of Pain Medicine

Volumn , Issue , 2011, Pages 358-364

  Schmader, Kenneth E ^a,b   Dworkin, Robert H ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882482842     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2242-0.00060-2     Document Type: Chapter

References (91)

1. RE Hope-Simpson (1965) The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58 9-20.
2. JW Gnann Jr and RJ Whitley (2002) Herpes zoster. N Engl J Med 347 340-346.
3. RE Hope-Simpson (1975) Postherpetic neuralgia. J R Coll Gen Pract 25 571-575.
4. JF Kurtzke (1984) Neuroepidemiology. Ann Neurol 16 265-277.
5. JG Donahue, PW Choo, JE Manson, et al. (1995) The incidence of herpes zoster. Arch Intern Med 155 1605-1609.
6. M Brisson, WJ Edmunds, B Law, et al. (2001) Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 127 305-314.
7. BP Yawn, P Saddier, P Wollan, et al. (2007) A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 82 1341-1349.
8. MN Oxman, MJ Levin, GR Johnson, et al. (2005) the Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 2271-2284.
9. AM Arvin (1996) Varicella-zoster virus. BN Fields, DM Knipe, PM Howley, et al., (Eds) Fields virology ed 3 Philadelphia: Lippincott-Raven Publishers
10. M Haanpää, P Laippala and T Nurmikko (1999) Pain and somatosensory dysfunction in acute herpes zoster. Clin J Pain 15 78-84.
11. M Haanpää, P Laippala and T Nurmikko (2000) Allodynia and pinprick hypesthesia in acute herpes zoster, and the development of postherpetic neuralgia. J Pain Symptom Manage 20 50-58.
12. RH Dworkin, EM Nagasako, RW Johnson, et al. (2001) Acute pain in herpes zoster: the famciclovir database project. Pain 94 113-119.
13. DH Gilden, AN Dueland, R Cohrs, et al. (1991) Preherpetic neuralgia. Neurology 41 1215-1218.
14. RH Dworkin and KE Schmader (2001) Epidemiology and natural history of herpes zoster and postherpetic neuralgia. CPN Watson, AA Gershon,(Eds) Herpes zoster and postherpetic neuralgia, 2nd revised and enlarged ed New York: Elsevier
15. J Katz, EM Cooper, RR Walther, et al. (2004) Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 39 342-348.
16. KE Schmader, R Sloane, C Pieper, et al. (2007) The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 23 490-497.
17. DH Gilden, RR Wright, SA Schneck, et al. (1994) Zoster sine herpete, a clinical variant. Ann Neurol 35 530-533.
18. K Galil, PW Choo, JG Donahue, et al. (1997) The sequelae of herpes zoster. Arch Intern Med 157 1209-1213.
19. RG Kost and SE Straus (1996) Postherpetic neuralgia: pathogenesis, treatment, and prevention. N Engl J Med 335 32-42.
20. SK Tyring, KR Beutner, BA Tucker, et al. (2000) Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 9 863-869.
21. Q Li, N Chen, J Yang, et al. (2009) Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2 CD006866
22. RH Dworkin, RW Johnson, J Breuer, et al. (2007) Recommendations for the management of herpes zoster. Clin Infect Dis 44 S1-S26.
23. RJ Whitley, H Weiss, JW Gnann Jr, et al. (1996) Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med 125 376-383.
24. L He, D Zhang, M Zhou, et al. (2008) Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev 1 CD005582
25. RH Dworkin, RL Barbano, SK Tyring, et al. (2009) Oxycodone or gabapentin for acute pain in herpes zoster: a randomized, placebo-controlled trial. Pain 142 209-217.
26. JD Berry and KL Petersen (2005) A single dose of gabapentin reduces acute pain and allodynia inpatients with herpes zoster. Neurology 65 444-447.
27. D Bowsher (1997) The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 13 327-331.
28. RH Dworkin (1999) Prevention of postherpetic neuralgia. Lancet 353 1636-1637.
29. AJM Van Wijck, W Opstelten, KG Moons, et al. (2006) The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet 367 219-224.
30. A Pasqualucci, V Pasqualucci, F Galla, et al. (2000) Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednislone. Acta Anaesthesiol Scand 44 910-918.
31. H Manabe, K Dan, K Hirata, et al. (2004) Optimum pain relief with continuous epidural infusion of local anesthetics shortens the duration of zoster-associated pain. Clin J Pain 20 302-308.
32. G Ji, J Niu, Y Shi, et al. (2009) The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg 109 1651-1655.
33. W Opstelten, AJM Van Wijck and RJ Stolker (2004) Interventions to prevent postherpetic neuralgia: cutaneous and percutaneous techniques. Pain 107 202-206.
34. R Harpaz, IR Ortega-Sanchez and JF Seward (2008) Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 57(RR–5), 1-30.
35. RH Dworkin and RK Portenoy (1996) Pain and its persistence in herpes zoster. Pain 67 241-251.
36. RH Dworkin and RK Portenoy (1994) Proposed classification of herpes zoster pain. Lancet 343 1648.
37. RA Desmond, HL Weiss, RB Arani, et al. (2002) Clinical applications for change-point analysis of herpes zoster pain. J Pain Symptom Manage 23 510-516.
38. BF Jung, RW Johnson, DRJ Griffin, et al. (2004) Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 62 1545-1551.
39. GJ Bennett (1997) Neuropathic pain: an overview. D Borsook,(Eds) Molecular neurobiology of pain Seattle: IASP Press
40. K Schmader (2001) Herpes zoster in older adults. Clin Infect Dis 32 1481-1486.
41. R van Seventer, A Sadosky, M Lucero, et al. (2006) A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing 35 132-137.
42. C Chidiac, J Bruxelle, JP Daures, et al. (2001) Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 33 62-69.
43. CPN Watson, VR Watt, M Chipman, et al. (1991) The prognosis with post-herpetic neuralgia. Pain 46 195-199.
44. JC Huff, JL Drucker, A Clemmer, et al. (1993) Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol (suppl 1), 93-96.
45. BB Bhala, C Ramamoorthy, D Bowsher, et al. (1988) Shingles and postherpetic neuralgia. Clin J Pain 4 169-174.
46. D Bowsher (1993) Sensory change in postherpetic neuralgia. CPN Watson,(Eds) Herpes zoster and postherpetic neuralgia Amsterdam: Elsevier 97-107.
47. D Bowsher (1992) Acute herpes zoster and postherpetic neuralgia: effects of acyclovir and outcome of treatment with amitriptyline. Br J Gen Pract 42 244-246.
48. RR De Moragas JM and RR Kierland (1957) The outcome of patients with herpes zoster. Arch Dermatol 75 193-196.
49. RJ Whitley, HL Weiss, SJ Soong, et al. (1999) Herpes zoster: risk categories for persistent pain. J Infect Dis 179 9-15.
50. GJ Bennett (1994) Hypotheses on the pathogenesis of herpes zoster–associated pain. Ann Neurol 35 S38-S41. (suppl)
51. HL Fields, M Rowbotham and R Baron (1998) Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 5 209-227.
52. MC Rowbotham, KL Petersen and HL Fields (1998) Is postherpetic neuralgia more than one disorder. Pain Forum 7 231-237.
53. CPN Watson, JH Deck, C Morshead, et al. (1991) Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 44 105-117.
54. MC Rowbotham, G Yosipovitch, MK Connolly, et al. (1996) Cutaneous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol Dis 3 205-214.
55. AL Oaklander (2001) The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain 92 139-145.
56. KL Petersen, HL Fields, J Brennum, et al. (2000) Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain 88 125-133.
57. MC Rowbotham, R Baron, KL Petersen (2001) Spectrum of pain mechanisms contributing to PHN. CPN Watson, AA Gershon, et al., (Eds) Herpes zoster and postherpetic neuralgia ed 2 New York: Elsevier Press 39-64.
58. MB Max (1995) Thirteen consecutive well-designed randomized trials show that antidepressants reduce pain in diabetic neuropathy and postherpetic neuralgia. Pain Forum 4 248-253.
59. RH Dworkin, M Backonja, MC Rowbotham, et al. (2003) Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60 1524-1534.
60. RM Dubinsky, H Kabbani, Z El-Chami, et al. (2004) Practice parameter: treatment of post-herpetic neuralgiaan evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 63 959-965.
61. K Hempenstall, TJ Nurmikko, RJ Johnson, et al. (2005) Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLOS Med 2(e164), 0628-0644.
62. N Attal, G Cruccu, M Haanpää, et al. (2006) for the EFNS Task Force: EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13 1153-1169.
63. RH Dworkin, AB O’Connor, M Backonja, et al. (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132 237-251.
64. DE Moulin, AJ Clark, I Gilron, et al. (2007) Canadian Pain Society: Pharmacological management of chronic neuropathic painconsensus statement and guidelines from the Canadian Pain Society. Pain Res Manage 12 13-21.
65. M Backonja, MS Wallace, ER Blonsky, et al. (2008) NGX–4010 C116 Study Group. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurology 7 1106-1112.
66. AB O’Connor, K Noyes and RG Holloway (2007) A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia. J Am Geriatr Soc 55 1176-1184.
67. MC Rowbotham, N Harden, B Stacey, et al. (1998) Gabapentin for the treatment postherpetic neuralgia: a randomized controlled trial. JAMA 280 1837-1842.
68. ASC Rice and S Maton (2001) Postherpetic Neuralgia Study Group: Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 94 215-224.
69. Neurogesx (March 13, 2010) Qutenza full prescribing information. http://www.qutenza.com/_docs/qutenza_full_PI_.pdf Accessed on
70. MC Rowbotham, PS Davies, C Verkempinck, et al. (1996) Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 65 39-44.
71. BS Galer, MC Rowbotham, J Perander, et al. (1999) Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 80 533-538.
72. MC Rowbotham, MC Reisner-Keller and HL Fields (1991) Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41 1024-1028.
73. CPN Watson and N Babul (1998) Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50 1837-1841.
74. SN Raja, JA Haythornthwaite, M Pappagallo, et al. (2002) Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 59 1015-1021.
75. RH Dworkin, AE Corbin, JP Young Jr, et al. (2003) Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60 1274-1283.
76. R Sabatowski, R Gálvez, DA Cherry, et al. (2004) Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain 109 26-35. 1008-045 Study Group
77. RA Moore, S Straube, PJ Wiffen, et al. (2009) Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 3 CD007076
78. F Boureau, P Legallicier and M Kabir-Ahmadi (2003) Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain 104 323-331.
79. T Saarto and PJ Wiffen (2007) Antidepressants for neuropathic pain. Cochrane Database Syst Rev 4 CD005454
80. RR Aparasu and SJ Sitzman (1999) Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm 56 433-439.
81. JR Mort and RR Aparasu (2002) Prescribing of psychotropics in the elderly: why is it so often inappropriate. CNS Drugs 16 99-109.
82. CPN Watson, L Vernich, M Chipman, et al. (1998) Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 51 1166-1171.
83. SP Roose, F Laghrissi-Thode, JS Kennedy, et al. (1998) Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279 287-291.
84. I Gilron, JM Bailey, D Tu, et al. (2005) Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352 1324-1334.
85. I Gilron, JM Bailey, D Tu, et al. (2009) Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 374 1252-1261.
86. CL Wu, A Marsh and RH Dworkin (2000) The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain 87 121-129.
87. NS Milligan and TP Nash (1985) Treatment of post-herpetic neuralgia: a review of 77 consecutive cases. Pain 23 381-386.
88. AP Winnie and PW Hartwell (1993) Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of postherpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 18 277-282.
89. N Kotani, T Kushikata, H Hashimoto, et al. (2000) Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med 343 1514-1519.
90. H Harke, P Gretenkort, HU Ladleif, et al. (2002) Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg 94 694-700.
91. DC Turk and RJ Gatchel (2002) Psychological approaches to pain management: a practitioner’s handbook. ed 2 New York: Guilford Press